Pharmaceuticals
Esteve acquires TerSera Therapeutics' specialized infusion therapies business unit
1 min
Catalan pharmaceutical company Esteve and US-based TerSera Therapeutics LLC have announced an agreement under which Esteve will acquire TerSera's specialty infusion therapies (IST) business unit. This acquisition allows Esteve to expand its presence in the United States.